The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.
Sources
Latest News
10:40
The Kremlin excludes Europe from the peace negotiations with Ukraine: “They can participate if they buy their own tickets”
10:38
SRI explains how Russia recruits vulnerable people for sabotage operations in Romania
10:36
The Likud party, led by Benjamin Netanyahu, accuses Arab factions of having “stolen” the elections in Israel
10:25
The Kremlin confirms that the Trump administration is discussing lifting sanctions imposed on Russia’s investment fund
10:25
Three old computers caused the signaling failure that preceded the rail collision in Spain, which left 68 people dead
See more news